Cardiometabolic Health Congress Expert Faculty Evaluate the Clinical…

The U.S. Food and Drug Administration (FDA) approved JUXTAPID™ (lomitapide), a new, first-in-class treatment option for clinical management of patients with homozygous familial hypercholesterolemia...

(PRWeb January 08, 2013)

Read the full story at http://www.prweb.com/releases/2013/1/prweb10293283.htm